Crinetics Pharmaceuticals Inc. (CRNX) NASDAQ

$46.81 2.38 (5.36%)

Market Cap: $3.26B

As of 03/28/24 04:00 PM EDT. Market closed.

(CRNX)

Crinetics Pharmaceuticals Inc. (CRNX)
NASDAQ

$46.81
2.38 (5.36%)

Market Cap: $3.26B

As of 03/28/24 04:00 PM EDT. Market closed.

Add to Portfolio

neuropeptide receptor targeted therapeutics for the treatment of endocrine diseases and cancers. we are driven by a passion for drug-hunting and tempered by a post-recession startup culture. our goal is to create new therapeutics that can make a meaningful difference in the lives of our ... read more

neuropeptide receptor targeted therapeutics for the treatment of endocrine diseases and cancers. we are driven by a passion for drug-hunting and tempered by a post-recession startup culture. our goal is to create new therapeutics that can make a meaningful difference in the lives of our patients. read less

COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
CEO Compensation (Base)
$409,913
CEO Compensation (Total)
$3.04M
URL
Address
10222 Barnes Canyon Rd Bldg 2, California, San Diego, 92121-2711.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
CEO
R. Scott Struthers
CEO Compensation (Base)
$409,913
CEO Compensation (Total)
$3.04M
Address
10222 Barnes Canyon Rd Bldg 2, California, San Diego, 92121-2711.
PRICE CHART FOR CRINETICS PHARMACEUTICALS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$44.64
Previous Close
$44.43
Days Range
$44.01 - $47.16
52 week range
$15.50 - $47.58
Volume
1,289,138
Avg. Volume (30 days)
954,928
Market Cap
$3.26B
Dividend Yield
-
P/E
(15.19)
Shares Outstanding
69,600,000
Open
$44.64
Previous Close
$44.43
Days Range
$44.01 - $47.16
52 week range
$15.50 - $47.58
Volume
1,289,138
Avg. Volume (30 days)
954,928
Market Cap
$3.26B
Dividend Yield
-
P/E
(15.19)
Shares Outstanding
69,600,000
FINANCIAL STATEMENTS FOR CRINETICS PHARMACEUTICALS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR CRINETICS PHARMACEUTICALS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Knight Jeff E.Chief Operating OfficerMar 22, 2024 Option Exercise$23.9830,000719,40084,939Mar 26, 2024, 04:30 PM
Knight Jeff E.Chief Operating OfficerMar 22, 2024 Sale$44.3132,3591,433,67554,939Mar 26, 2024, 04:30 PM
Pizzuti DanaChief Med and Dev OfficerMar 20, 2024 Option Exercise$16.8914,375242,79438,500Mar 22, 2024, 04:52 PM
Pizzuti DanaChief Med and Dev OfficerMar 20, 2024 Sale$44.0615,089664,76328,500Mar 22, 2024, 04:52 PM
Fust Matthew KDirectorMar 20, 2024 Option Exercise$20.9260,0001,254,97536,036Mar 22, 2024, 04:31 PM
Fust Matthew KDirectorMar 20, 2024 Sale$44.1460,0002,648,15018,536Mar 22, 2024, 04:31 PM
Pizzuti DanaChief Med and Dev OfficerMar 18, 2024 Option Exercise$38.1441115,67628,500Mar 20, 2024, 06:36 PM
Knight Jeff E.Chief Operating OfficerMar 18, 2024 Option Exercise$38.144,283163,35454,939Mar 20, 2024, 06:35 PM
Hassard JamesChief Commercial OfficerMar 18, 2024 Option Exercise$38.141,74166,40229,259Mar 20, 2024, 06:34 PM
Betz Stephen F.Chief Scientific OfficerMar 18, 2024 Option Exercise$38.143,655139,40292,643Mar 20, 2024, 06:33 PM
Wilson MarcCFOMar 18, 2024 Option Exercise$38.143,983151,912117,572Mar 20, 2024, 06:32 PM
Wilson MarcCFOMar 19, 2024 Sale$42.916,942297,881110,630Mar 20, 2024, 06:32 PM
Struthers Richard ScottPresident & CEOMar 18, 2024 Option Exercise$38.1412,687483,882237,835Mar 20, 2024, 06:31 PM
Betz Stephen F.Chief Scientific OfficerJan 25, 2024 Sale$37.263,000111,78073,298Jan 26, 2024, 05:50 PM
Betz Stephen F.Chief Scientific OfficerJan 10, 2024 Sale$37.653,000112,95076,298Jan 12, 2024, 04:12 PM
Pizzuti DanaChief Med and Dev OfficerJan 03, 2024 Option Exercise$16.8914,375242,79420,286Jan 04, 2024, 04:45 PM
Pizzuti DanaChief Med and Dev OfficerJan 03, 2024 Sale$35.0014,375503,1255,911Jan 04, 2024, 04:45 PM
Wilson MarcCFOJan 02, 2024 Option Exercise$9.2810,00092,800106,055Jan 04, 2024, 04:43 PM
Wilson MarcCFOJan 02, 2024 Sale$35.4710,000354,70096,055Jan 04, 2024, 04:43 PM
Betz Stephen F.Chief Scientific OfficerDec 26, 2023 Sale$35.893,000107,67079,298Dec 27, 2023, 05:20 PM
Pizzuti DanaChief Med and Dev OfficerDec 21, 2023 Option Exercise$16.899,583161,85715,494Dec 22, 2023, 06:45 PM
Pizzuti DanaChief Med and Dev OfficerDec 21, 2023 Sale$34.579,583331,2845,911Dec 22, 2023, 06:45 PM
Betz Stephen F.Chief Scientific OfficerDec 11, 2023 Sale$32.873,00098,61082,298Dec 13, 2023, 04:44 PM
Betz Stephen F.Chief Scientific OfficerNov 27, 2023 Sale$31.843,00095,52085,298Nov 29, 2023, 04:31 PM
Struthers Richard ScottPresident & CEONov 09, 2023 Option Exercise$1.9150,00095,500185,522Nov 13, 2023, 04:33 PM
Struthers Richard ScottPresident & CEONov 03, 2023 Option Exercise$9.28199,0821,847,481334,604Nov 06, 2023, 06:02 PM
Struthers Richard ScottPresident & CEONov 02, 2023 Option Exercise$9.289188,519136,440Nov 06, 2023, 06:02 PM
Struthers Richard ScottPresident & CEONov 02, 2023 Sale$29.9591827,494135,522Nov 06, 2023, 06:02 PM
Struthers Richard ScottPresident & CEONov 03, 2023 Sale$30.56199,0826,083,946135,522Nov 06, 2023, 06:02 PM
Wilson MarcCFONov 01, 2023 Option Exercise$9.2810,00092,800105,601Nov 03, 2023, 07:38 PM
Wilson MarcCFONov 01, 2023 Sale$28.7510,000287,50095,601Nov 03, 2023, 07:38 PM
Krasner Alan SethChief Medical OfficerOct 17, 2023 Option Exercise$12.017,00084,07050,210Oct 19, 2023, 05:01 PM
Krasner Alan SethChief Medical OfficerOct 17, 2023 Sale$30.007,000210,00043,210Oct 19, 2023, 05:01 PM
Struthers Richard ScottPresident & CEOAug 14, 2023 Option Exercise$1.9110,00019,100135,522Aug 16, 2023, 04:30 PM
Struthers Richard ScottPresident & CEOJul 13, 2023 Sale$20.3514,157288,095630,805Jul 13, 2023, 04:56 PM
Struthers Richard ScottPresident & CEOJul 12, 2023 Sale$20.1711,459231,128644,962Jul 13, 2023, 04:56 PM
Struthers Richard ScottPresident & CEOJul 11, 2023 Sale$20.1424,384491,094656,421Jul 13, 2023, 04:56 PM
Wilson MarcCFOJun 20, 2023 Option Exercise$9.2820,000185,600115,158Jun 21, 2023, 05:32 PM
Wilson MarcCFOJun 20, 2023 Sale$19.9730,922617,40395,158Jun 21, 2023, 05:32 PM
Struthers Richard ScottPresident & CEOJun 16, 2023 Sale$20.8150,0001,040,500680,805Jun 21, 2023, 05:27 PM
Vivaldi Coelho RogerioDirectorJun 08, 2023 Buy$22.065,000110,3005,000Jun 09, 2023, 08:00 AM
Pizzuti DanaChief Development OfficerApr 03, 2023 Option Exercise$15.984,28868,52212,712Apr 05, 2023, 07:12 PM
Pizzuti DanaChief Development OfficerApr 05, 2023 Sale$16.158,212132,6244,500Apr 05, 2023, 07:12 PM
Wilson MarcCFOMar 16, 2023 Option Exercise$17.121,66628,522106,080Mar 17, 2023, 05:11 PM
Struthers Richard ScottPresident & CEOMar 16, 2023 Option Exercise$17.124,62879,231125,522Mar 17, 2023, 05:10 PM
Krasner Alan SethChief Medical OfficerMar 16, 2023 Option Exercise$17.121,68728,88142,301Mar 17, 2023, 05:09 PM
Knight Jeff E.Chief Operating OfficerMar 16, 2023 Option Exercise$17.1258710,04934,400Mar 17, 2023, 05:08 PM
Betz Stephen F.Chief Scientific OfficerMar 16, 2023 Option Exercise$17.121,41024,13986,879Mar 17, 2023, 05:07 PM
Betz Stephen F.Chief Scientific OfficerFeb 01, 2023 Sale$19.593,12661,23864,689Feb 03, 2023, 04:30 PM
Betz Stephen F.Chief Scientific OfficerJan 25, 2023 Sale$21.078,336175,64067,815Jan 27, 2023, 04:26 PM
Betz Stephen F.Chief Scientific OfficerJan 17, 2023 Sale$18.003,12656,26876,151Jan 19, 2023, 04:28 PM
Betz Stephen F.Chief Scientific OfficerJan 03, 2023 Sale$18.353,12657,36279,277Jan 05, 2023, 04:23 PM
Betz Stephen F.Chief Scientific OfficerDec 15, 2022 Sale$16.003,12650,01682,403Dec 19, 2022, 05:11 PM
Betz Stephen F.Chief Scientific OfficerDec 01, 2022 Sale$17.843,12655,76884,968Dec 05, 2022, 05:28 PM
Betz Stephen F.Chief Scientific OfficerNov 15, 2022 Sale$18.723,12658,51988,094Nov 17, 2022, 04:46 PM
Betz Stephen F.Chief Scientific OfficerNov 01, 2022 Sale$18.523,12657,89491,220Nov 03, 2022, 04:35 PM
Betz Stephen F.Chief Scientific OfficerOct 17, 2022 Sale$17.733,12655,42494,346Oct 19, 2022, 05:34 PM
Struthers Richard ScottPresident & CEOOct 12, 2022 Option Exercise$1.9111,10021,20168,500Oct 14, 2022, 04:55 PM
Betz Stephen F.Chief Scientific OfficerOct 03, 2022 Sale$19.643,12661,39597,472Oct 05, 2022, 04:40 PM
Betz Stephen F.Chief Scientific OfficerSep 15, 2022 Sale$21.014,16887,570100,598Sep 19, 2022, 04:40 PM
Betz Stephen F.Chief Scientific OfficerSep 07, 2022 Sale$21.001,04221,884104,766Sep 09, 2022, 04:20 PM
Betz Stephen F.Chief Scientific OfficerMay 20, 2022 Option Exercise$11.021,33614,723108,934Sep 06, 2022, 04:20 PM
Betz Stephen F.Chief Scientific OfficerSep 01, 2022 Sale$18.593,12658,112105,808Sep 06, 2022, 04:20 PM
Knight Jeff E.Chief Operating OfficerMay 20, 2022 Option Exercise$17.441,15220,0916,102Jul 29, 2022, 04:26 PM
Knight Jeff E.Chief Operating OfficerJul 26, 2022 Sale$20.701,15223,8474,950Jul 29, 2022, 04:26 PM
Fust Matthew KDirectorJul 13, 2022 Option Exercise$1.455,7008,26518,236Jul 15, 2022, 04:30 PM
Fust Matthew KDirectorJul 13, 2022 Sale$20.965,700119,45512,536Jul 15, 2022, 04:30 PM
Betz Stephen F.Chief Scientific OfficerMay 02, 2022 Sale$20.103,24765,252107,598May 04, 2022, 05:01 PM
Betz Stephen F.Chief Scientific OfficerApr 18, 2022 Sale$25.815,664146,188110,845Apr 21, 2022, 05:00 PM
PERCEPTIVE ADVISORS LLC10% OwnerApr 18, 2022 Buy$22.22157,5153,499,9835,321,032Apr 18, 2022, 05:39 PM
Struthers Richard ScottPresident & CEOApr 13, 2022 Sale$26.83138,6433,719,625844,774Apr 15, 2022, 06:00 PM
Struthers Richard ScottPresident & CEOApr 05, 2022 Sale$25.3421,357541,225869,448Apr 07, 2022, 05:58 PM
Betz Stephen F.Chief Scientific OfficerApr 04, 2022 Sale$23.979,000215,761116,509Apr 06, 2022, 07:08 PM
Betz Stephen F.Chief Scientific OfficerApr 01, 2022 Sale$21.804,16490,775125,509Apr 01, 2022, 05:39 PM
Betz Stephen F.Chief Scientific OfficerMar 31, 2022 Sale$21.064,16487,700129,673Apr 01, 2022, 05:39 PM
Betz Stephen F.Chief Scientific OfficerMar 15, 2022 Sale$18.943,12359,150133,837Mar 17, 2022, 04:33 PM
Madan AjayChief Development OfficerMar 01, 2022 Sale$19.889,000178,920176,995Mar 02, 2022, 09:00 PM
Betz Stephen F.Chief Scientific OfficerMar 01, 2022 Sale$19.733,12361,617136,960Mar 02, 2022, 09:00 PM
Betz Stephen F.Chief Scientific OfficerFeb 15, 2022 Sale$18.643,12358,213123,583Feb 17, 2022, 04:34 PM
Madan AjayChief Development OfficerFeb 07, 2022 Sale$17.8313,411239,085172,045Feb 09, 2022, 05:00 PM
Betz Stephen F.Chief Scientific OfficerFeb 01, 2022 Sale$18.793,12358,681126,706Feb 03, 2022, 04:30 PM
Krasner Alan SethChief Medical OfficerJan 19, 2022 Option Exercise$12.016,70080,46715,011Jan 21, 2022, 04:54 PM
Krasner Alan SethChief Medical OfficerJan 19, 2022 Sale$21.216,700142,0808,311Jan 21, 2022, 04:54 PM
Betz Stephen F.Chief Scientific OfficerJan 18, 2022 Sale$23.294,16897,073128,875Jan 20, 2022, 04:47 PM
Betz Stephen F.Chief Scientific OfficerJan 03, 2022 Sale$28.027,168200,847133,043Jan 06, 2022, 04:37 PM
Betz Stephen F.Chief Scientific OfficerDec 28, 2021 Sale$27.953,00083,852140,211Dec 30, 2021, 07:19 PM
Betz Stephen F.Chief Scientific OfficerDec 15, 2021 Sale$24.145,668136,826143,211Dec 17, 2021, 04:28 PM
Betz Stephen F.Chief Scientific OfficerDec 01, 2021 Sale$27.385,668155,190148,879Dec 03, 2021, 04:36 PM
Betz Stephen F.Chief Scientific OfficerNov 16, 2021 Sale$27.971,50041,955154,547Nov 17, 2021, 05:01 PM
Betz Stephen F.Chief Scientific OfficerNov 15, 2021 Sale$26.755,668151,619156,047Nov 17, 2021, 05:01 PM
Betz Stephen F.Chief Scientific OfficerNov 08, 2021 Sale$28.423,900110,846161,715Nov 09, 2021, 05:44 PM
Betz Stephen F.Chief Scientific OfficerNov 05, 2021 Sale$27.9512,600352,195165,615Nov 09, 2021, 05:44 PM
Betz Stephen F.Chief Scientific OfficerNov 01, 2021 Sale$24.795,668140,510178,215Nov 03, 2021, 04:57 PM
Fust Matthew KDirectorNov 01, 2021 Option Exercise$1.918,95417,10221,490Nov 03, 2021, 04:55 PM
Fust Matthew KDirectorNov 01, 2021 Sale$25.508,954228,32712,536Nov 03, 2021, 04:55 PM
Madan AjayChief Development OfficerOct 28, 2021 Option Exercise$0.73106,38377,660184,671Nov 01, 2021, 07:11 PM
Betz Stephen F.Chief Scientific OfficerOct 27, 2021 Sale$24.003,00071,991183,883Oct 28, 2021, 05:00 PM
Betz Stephen F.Chief Scientific OfficerOct 21, 2021 Sale$21.101,04221,984186,883Oct 25, 2021, 04:28 PM
PERCEPTIVE ADVISORS LLC10% OwnerOct 25, 2021 Buy$19.801,200,00023,759,9995,163,517Oct 25, 2021, 02:47 PM
Fust Matthew KDirectorSep 08, 2021 Option Exercise$1.916,04611,54818,582Sep 09, 2021, 05:00 PM
Fust Matthew KDirectorSep 08, 2021 Sale$25.506,046154,17312,536Sep 09, 2021, 05:00 PM
Struthers Richard ScottPresident & CEOSep 07, 2021 Sale$25.0010,000250,00090,000Sep 09, 2021, 05:00 PM
Struthers Richard ScottPresident & CEOSep 07, 2021 Sale$25.0010,000250,00090,000Sep 09, 2021, 05:00 PM
Struthers Richard ScottPresident & CEOSep 07, 2021 Sale$25.0010,000250,00090,000Sep 09, 2021, 05:00 PM
Fust Matthew KDirectorJul 26, 2021 Option Exercise$1.915,0009,55017,536Jul 27, 2021, 08:00 PM
Fust Matthew KDirectorJul 26, 2021 Sale$19.595,00097,95012,536Jul 27, 2021, 08:00 PM
Fust Matthew KDirectorJul 19, 2021 Option Exercise$1.915,0009,55017,536Jul 20, 2021, 05:00 PM
Fust Matthew KDirectorJul 19, 2021 Sale$19.505,00097,50012,536Jul 20, 2021, 05:00 PM
Fust Matthew KDirectorJul 12, 2021 Option Exercise$1.915,0009,55017,536Jul 13, 2021, 05:00 PM
Fust Matthew KDirectorJul 12, 2021 Sale$20.715,000103,55012,536Jul 13, 2021, 05:00 PM
PERCEPTIVE ADVISORS LLC10% OwnerApr 08, 2021 Buy$16.44304,1364,999,9963,963,517Apr 09, 2021, 09:00 AM
Struthers Richard ScottPresident & CEODec 03, 2020 Buy$13.104,00052,4004,000Dec 04, 2020, 04:59 PM
Struthers Richard ScottPresident & CEODec 02, 2020 Buy$12.601,00012,6001,000Dec 04, 2020, 04:59 PM
Struthers Richard ScottPresident & CEOJul 16, 2020 Sale$14.4617,500253,108890,805Jul 17, 2020, 05:05 PM
Struthers Richard ScottPresident & CEOJul 15, 2020 Sale$15.3017,500267,722908,305Jul 17, 2020, 05:05 PM
WIERENGA WENDALLDirectorApr 28, 2020 Option Exercise$0.7325,32918,49099,846Apr 29, 2020, 05:01 PM
PERCEPTIVE ADVISORS LLC10% OwnerApr 17, 2020 Buy$14.001,071,42814,999,9923,659,381Apr 20, 2020, 08:30 AM
Vivo Capital VIII, LLC10% OwnerApr 17, 2020 Sale$15.4084,5981,302,8092,162,587Apr 17, 2020, 06:38 PM
Vivo Capital VIII, LLC10% OwnerApr 16, 2020 Sale$15.2030,190458,8882,236,920Apr 17, 2020, 06:38 PM
Vivo Capital VIII, LLC10% OwnerApr 15, 2020 Sale$15.50215,8103,345,0552,263,447Apr 17, 2020, 06:38 PM
Vivo Capital VIII, LLC10% OwnerApr 07, 2020 Sale$14.206,11586,8332,453,072Apr 07, 2020, 07:27 PM
Vivo Capital VIII, LLC10% OwnerApr 03, 2020 Sale$13.80300,0004,140,0002,458,445Apr 07, 2020, 07:27 PM
Vivo Capital VIII, LLC10% OwnerMar 09, 2020 Sale$19.5052810,2962,722,045Mar 11, 2020, 05:12 PM
Vivo Capital VIII, LLC10% OwnerFeb 10, 2020 Sale$21.407,555161,6772,722,392Feb 11, 2020, 08:00 PM
Vivo Capital VIII, LLC10% OwnerFeb 07, 2020 Sale$22.005,905129,9102,723,843Feb 11, 2020, 08:00 PM
Vivo Capital VIII, LLC10% OwnerFeb 04, 2020 Sale$22.8013,460306,8882,724,977Feb 06, 2020, 07:22 PM
Vivo Capital VIII, LLC10% OwnerJan 31, 2020 Sale$21.705,400117,1802,727,561Jan 31, 2020, 08:00 PM
Vivo Capital VIII, LLC10% OwnerJan 30, 2020 Sale$22.107,600167,9602,728,598Jan 31, 2020, 08:00 PM
Vivo Capital VIII, LLC10% OwnerJan 29, 2020 Sale$22.2013,920309,0242,730,057Jan 31, 2020, 08:00 PM
Fust Matthew KDirectorDec 16, 2019 Option Exercise$1.913,5006,68516,036Dec 18, 2019, 06:32 PM
Fust Matthew KDirectorDec 16, 2019 Sale$22.503,50078,75012,536Dec 18, 2019, 06:32 PM
Struthers Richard ScottPresident & CEOAug 05, 2019 Option Exercise$1.9110,00019,1001,225,805Aug 07, 2019, 07:31 PM
5AM Ventures IV, L.P.Former 10% holderJun 21, 2019 Sale$22.20250,0005,550,0002,267,797Jun 25, 2019, 07:03 PM
Vivo Capital VIII, LLC10% OwnerMar 20, 2019 Sale$22.25417,0009,278,2502,732,730Mar 25, 2019, 06:04 AM
5AM Ventures IV, L.P.10% OwnerMar 18, 2019 Sale$24.25154,8393,754,9542,507,797Mar 20, 2019, 04:48 PM
5AM Ventures IV, L.P.10% OwnerJan 22, 2019 Sale$21.88262,1535,734,5973,107,642Jan 24, 2019, 07:01 PM
PERCEPTIVE ADVISORS LLCDirectorJul 20, 2018 Buy$17.00400,0006,800,0002,587,953Aug 27, 2018, 06:12 PM
PERCEPTIVE ADVISORS LLCDirectorJul 18, 2018 Buy$21.30307,6486,552,902307,648Aug 27, 2018, 06:12 PM
5AM Ventures IV, L.P.10% OwnerJul 20, 2018 Buy$17.00115,0001,955,0003,359,309Jul 20, 2018, 07:02 PM
PERCEPTIVE ADVISORS LLCDirectorJul 20, 2018 Buy$17.00400,0006,800,0002,280,305Jul 20, 2018, 05:19 PM
Vivo Capital VIII, LLC10% OwnerJul 20, 2018 Buy$18.62353,1806,575,4213,025,339Jul 20, 2018, 04:50 PM
Krasner Alan SethChief Medical OfficerJul 20, 2018 Buy$17.002,00034,0002,000Jul 20, 2018, 04:06 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Knight Jeff E.Chief Operating Officer03/22/2024719,400
Knight Jeff E.Chief Operating Officer03/22/20241,433,675
Pizzuti DanaChief Med and Dev Officer03/20/2024242,794
Pizzuti DanaChief Med and Dev Officer03/20/2024664,763
Fust Matthew KDirector03/20/20241,254,975
Fust Matthew KDirector03/20/20242,648,150
Pizzuti DanaChief Med and Dev Officer03/18/202415,676
Knight Jeff E.Chief Operating Officer03/18/2024163,354
Hassard JamesChief Commercial Officer03/18/202466,402
Betz Stephen F.Chief Scientific Officer03/18/2024139,402
Wilson MarcCFO03/18/2024151,912
Wilson MarcCFO03/19/2024297,881
Struthers Richard ScottPresident & CEO03/18/2024483,882
Betz Stephen F.Chief Scientific Officer01/25/2024111,780
Betz Stephen F.Chief Scientific Officer01/10/2024112,950
Pizzuti DanaChief Med and Dev Officer01/03/2024242,794
Pizzuti DanaChief Med and Dev Officer01/03/2024503,125
Wilson MarcCFO01/02/202492,800
Wilson MarcCFO01/02/2024354,700
Betz Stephen F.Chief Scientific Officer12/26/2023107,670
Pizzuti DanaChief Med and Dev Officer12/21/2023161,857
Pizzuti DanaChief Med and Dev Officer12/21/2023331,284
Betz Stephen F.Chief Scientific Officer12/11/202398,610
Betz Stephen F.Chief Scientific Officer11/27/202395,520
Struthers Richard ScottPresident & CEO11/09/202395,500
Struthers Richard ScottPresident & CEO11/03/20231,847,481
Struthers Richard ScottPresident & CEO11/02/20238,519
Struthers Richard ScottPresident & CEO11/02/202327,494
Struthers Richard ScottPresident & CEO11/03/20236,083,946
Wilson MarcCFO11/01/202392,800
Wilson MarcCFO11/01/2023287,500
Krasner Alan SethChief Medical Officer10/17/202384,070
Krasner Alan SethChief Medical Officer10/17/2023210,000
Struthers Richard ScottPresident & CEO08/14/202319,100
Struthers Richard ScottPresident & CEO07/13/2023288,095
Struthers Richard ScottPresident & CEO07/12/2023231,128
Struthers Richard ScottPresident & CEO07/11/2023491,094
Wilson MarcCFO06/20/2023185,600
Wilson MarcCFO06/20/2023617,403
Struthers Richard ScottPresident & CEO06/16/20231,040,500
Vivaldi Coelho RogerioDirector06/08/2023110,300
Pizzuti DanaChief Development Officer04/03/202368,522
Pizzuti DanaChief Development Officer04/05/2023132,624
Wilson MarcCFO03/16/202328,522
Struthers Richard ScottPresident & CEO03/16/202379,231
Krasner Alan SethChief Medical Officer03/16/202328,881
Knight Jeff E.Chief Operating Officer03/16/202310,049
Betz Stephen F.Chief Scientific Officer03/16/202324,139
Betz Stephen F.Chief Scientific Officer02/01/202361,238
Betz Stephen F.Chief Scientific Officer01/25/2023175,640
Betz Stephen F.Chief Scientific Officer01/17/202356,268
Betz Stephen F.Chief Scientific Officer01/03/202357,362
Betz Stephen F.Chief Scientific Officer12/15/202250,016
Betz Stephen F.Chief Scientific Officer12/01/202255,768
Betz Stephen F.Chief Scientific Officer11/15/202258,519
Betz Stephen F.Chief Scientific Officer11/01/202257,894
Betz Stephen F.Chief Scientific Officer10/17/202255,424
Struthers Richard ScottPresident & CEO10/12/202221,201
Betz Stephen F.Chief Scientific Officer10/03/202261,395
Betz Stephen F.Chief Scientific Officer09/15/202287,570
Betz Stephen F.Chief Scientific Officer09/07/202221,884
Betz Stephen F.Chief Scientific Officer05/20/202214,723
Betz Stephen F.Chief Scientific Officer09/01/202258,112
Knight Jeff E.Chief Operating Officer05/20/202220,091
Knight Jeff E.Chief Operating Officer07/26/202223,847
Fust Matthew KDirector07/13/20228,265
Fust Matthew KDirector07/13/2022119,455
Betz Stephen F.Chief Scientific Officer05/02/202265,252
Betz Stephen F.Chief Scientific Officer04/18/2022146,188
PERCEPTIVE ADVISORS LLC10% Owner04/18/20223,499,983
Struthers Richard ScottPresident & CEO04/13/20223,719,625
Struthers Richard ScottPresident & CEO04/05/2022541,225
Betz Stephen F.Chief Scientific Officer04/04/2022215,761
Betz Stephen F.Chief Scientific Officer04/01/202290,775
Betz Stephen F.Chief Scientific Officer03/31/202287,700
Betz Stephen F.Chief Scientific Officer03/15/202259,150
Madan AjayChief Development Officer03/01/2022178,920
Betz Stephen F.Chief Scientific Officer03/01/202261,617
Betz Stephen F.Chief Scientific Officer02/15/202258,213
Madan AjayChief Development Officer02/07/2022239,085
Betz Stephen F.Chief Scientific Officer02/01/202258,681
Krasner Alan SethChief Medical Officer01/19/202280,467
Krasner Alan SethChief Medical Officer01/19/2022142,080
Betz Stephen F.Chief Scientific Officer01/18/202297,073
Betz Stephen F.Chief Scientific Officer01/03/2022200,847
Betz Stephen F.Chief Scientific Officer12/28/202183,852
Betz Stephen F.Chief Scientific Officer12/15/2021136,826
Betz Stephen F.Chief Scientific Officer12/01/2021155,190
Betz Stephen F.Chief Scientific Officer11/16/202141,955
Betz Stephen F.Chief Scientific Officer11/15/2021151,619
Betz Stephen F.Chief Scientific Officer11/08/2021110,846
Betz Stephen F.Chief Scientific Officer11/05/2021352,195
Betz Stephen F.Chief Scientific Officer11/01/2021140,510
Fust Matthew KDirector11/01/202117,102
Fust Matthew KDirector11/01/2021228,327
Madan AjayChief Development Officer10/28/202177,660
Betz Stephen F.Chief Scientific Officer10/27/202171,991
Betz Stephen F.Chief Scientific Officer10/21/202121,984
PERCEPTIVE ADVISORS LLC10% Owner10/25/202123,759,999
Fust Matthew KDirector09/08/202111,548
Fust Matthew KDirector09/08/2021154,173
Struthers Richard ScottPresident & CEO09/07/2021250,000
Struthers Richard ScottPresident & CEO09/07/2021250,000
Struthers Richard ScottPresident & CEO09/07/2021250,000
Fust Matthew KDirector07/26/20219,550
Fust Matthew KDirector07/26/202197,950
Fust Matthew KDirector07/19/20219,550
Fust Matthew KDirector07/19/202197,500
Fust Matthew KDirector07/12/20219,550
Fust Matthew KDirector07/12/2021103,550
PERCEPTIVE ADVISORS LLC10% Owner04/08/20214,999,996
Struthers Richard ScottPresident & CEO12/03/202052,400
Struthers Richard ScottPresident & CEO12/02/202012,600
Struthers Richard ScottPresident & CEO07/16/2020253,108
Struthers Richard ScottPresident & CEO07/15/2020267,722
WIERENGA WENDALLDirector04/28/202018,490
PERCEPTIVE ADVISORS LLC10% Owner04/17/202014,999,992
Vivo Capital VIII, LLC10% Owner04/17/20201,302,809
Vivo Capital VIII, LLC10% Owner04/16/2020458,888
Vivo Capital VIII, LLC10% Owner04/15/20203,345,055
Vivo Capital VIII, LLC10% Owner04/07/202086,833
Vivo Capital VIII, LLC10% Owner04/03/20204,140,000
Vivo Capital VIII, LLC10% Owner03/09/202010,296
Vivo Capital VIII, LLC10% Owner02/10/2020161,677
Vivo Capital VIII, LLC10% Owner02/07/2020129,910
Vivo Capital VIII, LLC10% Owner02/04/2020306,888
Vivo Capital VIII, LLC10% Owner01/31/2020117,180
Vivo Capital VIII, LLC10% Owner01/30/2020167,960
Vivo Capital VIII, LLC10% Owner01/29/2020309,024
Fust Matthew KDirector12/16/20196,685
Fust Matthew KDirector12/16/201978,750
Struthers Richard ScottPresident & CEO08/05/201919,100
5AM Ventures IV, L.P.Former 10% holder06/21/20195,550,000
Vivo Capital VIII, LLC10% Owner03/20/20199,278,250
5AM Ventures IV, L.P.10% Owner03/18/20193,754,954
5AM Ventures IV, L.P.10% Owner01/22/20195,734,597
PERCEPTIVE ADVISORS LLCDirector07/20/20186,800,000
PERCEPTIVE ADVISORS LLCDirector07/18/20186,552,902
5AM Ventures IV, L.P.10% Owner07/20/20181,955,000
PERCEPTIVE ADVISORS LLCDirector07/20/20186,800,000
Vivo Capital VIII, LLC10% Owner07/20/20186,575,421
Krasner Alan SethChief Medical Officer07/20/201834,000
Load More Insider Transactions
FUNDS WITH A POSITION IN CRINETICS PHARMACEUTICALS INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
BLACKROCK INC.5,345,1140.00485%10.31%Other
DRIEHAUS CAPITAL MANAGEMENT LLC5,039,9572.16%-1.8%Growth
ORBIMED ADVISORS LLC1,667,3601.18%-42.43%Other
GEODE CAPITAL MANAGEMENT, LLC1,352,6720.00504%6.54%Other
FISHER ASSET MANAGEMENT, LLC441,2950.0083%719.34%Other
FARALLON CAPITAL MANAGEMENT LLC122,9040.02%-66.04%Event Driven, Value
VIVO CAPITAL, LLC350,0001.02%No changeOther
CANDRIAM S.C.A.288,0110.07%NewOther
RENAISSANCE TECHNOLOGIES LLC11,7000.00064%-92.85%Other
UBS OCONNOR LLC30,000 (Call)0.00485%-50%Value
D. E. SHAW & CO., INC.17,0050.00053%-63.39%Other
ALPS ADVISORS INC46,0250.01%14.13%Other
TUDOR INVESTMENT CORP ET AL39,7640.01%20.5%Event Driven, Other
UBS OCONNOR LLC35,000 (Put)0.00002%ExitedValue
UBS OCONNOR LLC10,0380.03%-61.62%Value
AQR CAPITAL MANAGEMENT LLC6,6860.00045%NewOther
CHANGE IN SHARES OUTSTANDING FOR CRINETICS PHARMACEUTICALS INC
STOCK BUYBACKS FOR CRINETICS PHARMACEUTICALS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
18.43%
1Q
12/31/2023
06/30/2023
23.95%
2Q
12/31/2023
03/31/2023
24.80%
3Q
12/31/2023
12/31/2022
24.91%
4Q
12/31/2023
09/30/2022
25.12%
5Q
12/31/2023
06/30/2022
28.09%
6Q
12/31/2023
03/31/2022
41.00%
7Q
12/31/2023
12/31/2021
48.50%
8Q
12/31/2023
09/30/2021
75.61%
9Q
12/31/2023
06/30/2021
81.53%
10Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
18.43%
1Q
06/30/2023
23.95%
2Q
03/31/2023
24.80%
3Q
12/31/2022
24.91%
4Q
09/30/2022
25.12%
5Q
06/30/2022
28.09%
6Q
03/31/2022
41.00%
7Q
12/31/2021
48.50%
8Q
09/30/2021
75.61%
9Q
06/30/2021
81.53%
10Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR CRINETICS PHARMACEUTICALS INC
LOADING...